These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 19455675)

  • 1. OX40 costimulation can abrogate Foxp3+ regulatory T cell-mediated suppression of antitumor immunity.
    Kitamura N; Murata S; Ueki T; Mekata E; Reilly RT; Jaffee EM; Tani T
    Int J Cancer; 2009 Aug; 125(3):630-8. PubMed ID: 19455675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OX40 costimulation turns off Foxp3+ Tregs.
    Vu MD; Xiao X; Gao W; Degauque N; Chen M; Kroemer A; Killeen N; Ishii N; Li XC
    Blood; 2007 Oct; 110(7):2501-10. PubMed ID: 17575071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OX40/OX40L costimulation affects induction of Foxp3+ regulatory T cells in part by expanding memory T cells in vivo.
    Xiao X; Kroemer A; Gao W; Ishii N; Demirci G; Li XC
    J Immunol; 2008 Sep; 181(5):3193-201. PubMed ID: 18713990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights on OX40 in the control of T cell immunity and immune tolerance in vivo.
    Xiao X; Gong W; Demirci G; Liu W; Spoerl S; Chu X; Bishop DK; Turka LA; Li XC
    J Immunol; 2012 Jan; 188(2):892-901. PubMed ID: 22147766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of STAT3 in CD4+CD25+FOXP3+ regulatory lymphocyte generation: implications in graft-versus-host disease and antitumor immunity.
    Pallandre JR; Brillard E; Créhange G; Radlovic A; Remy-Martin JP; Saas P; Rohrlich PS; Pivot X; Ling X; Tiberghien P; Borg C
    J Immunol; 2007 Dec; 179(11):7593-604. PubMed ID: 18025205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble OX40L and JAG1 Induce Selective Proliferation of Functional Regulatory T-Cells Independent of canonical TCR signaling.
    Kumar P; Alharshawi K; Bhattacharya P; Marinelarena A; Haddad C; Sun Z; Chiba S; Epstein AL; Prabhakar BS
    Sci Rep; 2017 Jan; 7():39751. PubMed ID: 28045060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OX40 costimulation synergizes with GM-CSF whole-cell vaccination to overcome established CD8+ T cell tolerance to an endogenous tumor antigen.
    Murata S; Ladle BH; Kim PS; Lutz ER; Wolpoe ME; Ivie SE; Smith HM; Armstrong TD; Emens LA; Jaffee EM; Reilly RT
    J Immunol; 2006 Jan; 176(2):974-83. PubMed ID: 16393983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OX40 controls islet allograft tolerance in CD154 deficient mice by regulating FOXP3+ Tregs.
    Chen M; Xiao X; Demirci G; Li XC
    Transplantation; 2008 Jun; 85(11):1659-62. PubMed ID: 18551075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OX40 Agonist Tumor Immunotherapy Does Not Impact Regulatory T Cell Suppressive Function.
    Polesso F; Sarker M; Weinberg AD; Murray SE; Moran AE
    J Immunol; 2019 Oct; 203(7):2011-2019. PubMed ID: 31434709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of CFSE to monitor ex vivo regulatory T-cell suppression of CD4+ and CD8+ T-cell proliferation within unseparated mononuclear cells from malignant and non-malignant human lymph node biopsies.
    Hilchey SP; Bernstein SH
    Immunol Invest; 2007; 36(5-6):629-48. PubMed ID: 18161522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
    Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
    J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4+CD25+ Regulatory T Cells Inhibit Natural Killer Cell Hepatocytotoxicity of Hepatitis B Virus Transgenic Mice via Membrane-Bound TGF-β and OX40.
    Chen Y; Sun R; Wu X; Cheng M; Wei H; Tian Z
    J Innate Immun; 2016; 8(1):30-42. PubMed ID: 26067079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct roles for the OX40-OX40 ligand interaction in regulatory and nonregulatory T cells.
    Takeda I; Ine S; Killeen N; Ndhlovu LC; Murata K; Satomi S; Sugamura K; Ishii N
    J Immunol; 2004 Mar; 172(6):3580-9. PubMed ID: 15004159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agonist anti-GITR monoclonal antibody induces melanoma tumor immunity in mice by altering regulatory T cell stability and intra-tumor accumulation.
    Cohen AD; Schaer DA; Liu C; Li Y; Hirschhorn-Cymmerman D; Kim SC; Diab A; Rizzuto G; Duan F; Perales MA; Merghoub T; Houghton AN; Wolchok JD
    PLoS One; 2010 May; 5(5):e10436. PubMed ID: 20454651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical role of OX40 signaling in the TCR-independent phase of human and murine thymic Treg generation.
    Kumar P; Marinelarena A; Raghunathan D; Ragothaman VK; Saini S; Bhattacharya P; Fan J; Epstein AL; Maker AV; Prabhakar BS
    Cell Mol Immunol; 2019 Feb; 16(2):138-153. PubMed ID: 29578532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive drugs on inducing Ag-specific CD4(+)CD25(+)Foxp3(+) Treg cells during immune response in vivo.
    Wu T; Zhang L; Xu K; Sun C; Lei T; Peng J; Liu G; Wang R; Zhao Y
    Transpl Immunol; 2012 Aug; 27(1):30-8. PubMed ID: 22613676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4
    Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET
    J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined targeting of costimulatory (OX40) and coinhibitory (CTLA-4) pathways elicits potent effector T cells capable of driving robust antitumor immunity.
    Redmond WL; Linch SN; Kasiewicz MJ
    Cancer Immunol Res; 2014 Feb; 2(2):142-53. PubMed ID: 24778278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costimulation of CD8 T cell responses by OX40.
    Bansal-Pakala P; Halteman BS; Cheng MH; Croft M
    J Immunol; 2004 Apr; 172(8):4821-5. PubMed ID: 15067059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OX40- and CD27-mediated costimulation synergizes with anti-PD-L1 blockade by forcing exhausted CD8+ T cells to exit quiescence.
    Buchan S; Manzo T; Flutter B; Rogel A; Edwards N; Zhang L; Sivakumaran S; Ghorashian S; Carpenter B; Bennett C; Freeman GJ; Sykes M; Croft M; Al-Shamkhani A; Chakraverty R
    J Immunol; 2015 Jan; 194(1):125-133. PubMed ID: 25404365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.